| No. |
Date |
Title |
Institution(s) |
| |
1.20.2020 |
How to keep boron inside cells during radiotherapy: a simple novel approach to cancer treatment |
Tokyo Institute of Technology, Kyoto University, iCONM, STELLA PHARMA CORPORATION |
| |
12.24.2019 |
Succeeded for the first time in highly efficient and reversible conversion of 2D/3D structures by artificial chaperone |
Tokyo Institute of Technology |
| |
12.2.2019 |
Information on the 6th COINS Symposium “King SkyFront Bridgeｓ the World” |
iCONM |
| |
11.7.2019 |
Information on the academic luncheon seminar
“Make a dream: Development and Social Implementation of Nanomachines that Break the BBB” |
iCONM、Braizon Therapeutics, Inc. |
| |
10.24.2019 |
The University of Tokyo develops an exosome array chip that enables single nanoparticle measurement |
The University of Tokyo |
| |
10.23.2019 |
A novel technology has been developed to convert the double helix structure of DNA into a single strand of DNA (ssDNA), roll it into a compact form, and encapsulate it inside a smart nanomachine |
iCONM, National Institutes for Quantum and Radiological Science and Technology |
| |
8.20.2019 |
AccuRna signs Feasibility Study Agreement with
Astellas Innovation Management LLC |
AccuRna |
| |
7.4.2019 |
Enhancement of Motor Function Recovery After Spinal Cord Injury in Mice by Delivery of Brain Derived Neurotrophic Factor mRNA |
iCONM、Tokyo Medical and Dental University |
| |
6.28.2019 |
Nanomachines that carry nucleic acid drug for the fundamental treatment of hereditary intractable disease.
Launch crowdfunding for R&D and disease enlightenment |
iCONM、academist, inc. |
| |
4.25.2019 |
Developing a nanomachine which associates with nucleic acid pharmaceuticals in a rendezvous like manner in vivo to target brain tumors |
Faculty of Engineering, University of Tokyo |
| |
4.24.2019 |
New nanomedicine slips through the cracks |
The University of Tokyo |
| |
4.23.2019 |
Developing a nanomachine which associates with nucleic acid pharmaceuticals in a rendezvous like manner in vivo to target brain tumors |
iCONM, The University of Tokyo |
